Scientists attempt gene fix for rare immune disease
NCT ID NCT00778882
Summary
This early-stage trial aimed to test a gene therapy for males with a rare inherited immune disorder called chronic granulomatous disease (CGD). The approach involved collecting a patient's own blood stem cells, using a modified virus to insert a corrected gene into them, and then returning them to the patient. The goal was to see if this could safely restore the immune system's ability to fight infections, potentially offering a cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRANULOMATOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, 110-744, South Korea
Conditions
Explore the condition pages connected to this study.